JB
SKYE icon

Julian Baker’s Skye Bioscience SKYE Stock Holding History

Julian Baker’s Portfolio SKYE Stock Details SKYE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09M Hold
1,575,243
– – 0.01% 80
2026
Q1 		$968K Buy
1,575,243
+124,605
+9% +$102K 0.01% 80
2025
Q4 		$1.09M Hold
1,450,638
– – 0.01% 81
2025
Q3 		$5.7M Hold
1,450,638
– – 0.04% 71
2025
Q2 		$6.06M Hold
1,450,638
– – 0.06% 63
2025
Q1 		$2.31M Hold
1,450,638
– – 0.03% 72
2024
Q4 		$4.11M Buy
1,450,638
+16,004
+1% +$66.9K 0.04% 74
2024
Q3 		$5.61M Buy
1,434,634
+934,634
+187% +$5.24M 0.06% 64
2024
Q2 		$4M Buy
+500,000
New +$5.93M 0.05% 72

Other funds holding SKYE

5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Julian Baker's SKYE Position: Q2 2026 in Review

Julian Baker held its Skye Bioscience (SKYE) position steady in Q2 2026 at 1,575,243 shares worth $1.09M. The position accounts for 0.01% of the portfolio, ranked #80.

Julian Baker first reported a position in SKYE in Q2 2024 and has held it in 9 quarters since. The position peaked at $6.06M in Q2 2025. 43 funds tracked by Wall St. Rank hold SKYE as of Q2 2026.

  • Julian Baker held 1,575,243 shares of Skye Bioscience worth $1.09M as of Q2 2026.
  • Julian Baker left its Skye Bioscience share count unchanged in Q2 2026.
  • Skye Bioscience made up 0.01% of Julian Baker's portfolio in Q2 2026, its #80 holding.
  • Julian Baker first reported a position in Skye Bioscience in Q2 2024 and has held it in 9 quarters since.
  • Julian Baker's Skye Bioscience position peaked at $6.06M in Q2 2025.
  • 43 funds tracked by Wall St. Rank held Skye Bioscience as of Q2 2026.

Based on Baker Bros. Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.